A comprehensive view of US National Institute of Allergy and Infectious Diseases (NIAID). This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Thermo Fisher receives five-year grant to provide a Transplantation Statistical and Clinical Coordinating Center for the NIAID; the United Network for Organ Sharing reports over 40,000 organ transplants were performed in 2022

Mount Sinai's Icahn School of Medicine gets US$15.1M grant from NIAID for five-year study of immune rejection of transplanted organs; more than 40,000 transplants occur in US annually, but about 30% are lost due to rejection within the first five years

First-in-human trial of oral HOPO 14-1 drug to remove radioactive contamination begins in US; HOPO 14-1 is up to 100 times more effective than intravenous DTPA at binding and removing radioactive elements

Ask us about our Government & Public Policy market view

Trending Chart

Interactive chart with headline count